Matthew N Alder Selected Research

olfactomedin

1/2021	A neutrophil subset defined by intracellular olfactomedin 4 is associated with mortality in sepsis.
1/2021	Olfactomedin 4-Positive Neutrophils Are Upregulated after Hemorrhagic Shock.
1/2019	Olfactomedin 4 marks a subset of neutrophils in mice.
4/2017	Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew N Alder Research Topics

Disease

5	Sepsis (Septicemia) 11/2022 - 07/2014
3	Septic Shock (Toxic Shock Syndrome) 11/2022 - 04/2017
1	Multiple Organ Failure (MODS) 11/2022
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2021
1	Hemorrhagic Shock 01/2021
1	Low Cardiac Output 01/2018
1	Thrombotic Microangiopathies 01/2017
1	Leukemia 10/2013
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2013
1	Anthrax 12/2005

Drug/Important Bio-Agent (IBA)

4	olfactomedinIBA 01/2021 - 04/2017
3	Biomarkers (Surrogate Marker)IBA 11/2022 - 07/2014
2	Glycoproteins (Glycoprotein)IBA 01/2021 - 01/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2018 - 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 09/2018
1	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2018
1	CatecholaminesIBA 01/2018
1	Biological ProductsIBA 07/2014
1	Proteins (Proteins, Gene)FDA Link 10/2013
1	Anti-Idiotypic AntibodiesIBA 10/2013
1	EpitopesIBA 10/2013
1	AntibodiesIBA 10/2013
1	AntigensIBA 12/2005

Therapy/Procedure

2	Therapeutics 11/2022 - 07/2014
1	Hematopoietic Stem Cell Transplantation 01/2017